Colgate-Palmolive (NYSE:CL) Shares Sold by Fiera Capital Corp

Fiera Capital Corp trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 992,297 shares of the company's stock after selling 10,771 shares during the quarter. Fiera Capital Corp owned 0.12% of Colgate-Palmolive worth $103,010,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $53,000. Finally, Gradient Investments LLC lifted its holdings in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after purchasing an additional 400 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded up $1.82 during midday trading on Friday, hitting $92.59. 4,567,864 shares of the company's stock traded hands, compared to its average volume of 4,378,513. Colgate-Palmolive has a 1 year low of $74.67 and a 1 year high of $109.30. The firm has a fifty day moving average of $100.91 and a 200 day moving average of $98.37. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a market capitalization of $75.65 billion, a price-to-earnings ratio of 26.53, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.16%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Barclays upped their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a report on Monday, July 29th. HSBC restated a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a "hold" rating in a report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.